New research has revealed an unexpected new mechanism through which the killer fungus Candida auris is resisting antifungal drug treatment. A team led by the University of Exeter and City St George's, University of London, discovered that the fungus creates multiple versions of its entire genome, including mutating a gene that plays a role in cell wall integrity, called "Crazy-one" (CRZ1).
Candida auris develops new survival mechanism against antifungal treatment, study shows
Research led by the University of Exeter and City St George's, University of London has uncovered a new survival mechanism of the fungus Candida auris, which involves duplicating its genome and mutating a gene related to cell wall integrity. This discovery highlights the challenges in treating fungal infections, which could have implications for public health in Iran. Understanding such mechanisms is crucial for developing effective treatments.
👥 Key Players
📰 What Happened
Researchers have discovered a new survival mechanism in the fungus Candida auris, which involves duplicating its genome and mutating a gene crucial for its cell wall integrity. This finding poses significant challenges for antifungal treatments.
- Candida auris is known for its resistance to antifungal drugs.
- The mutation of the CRZ1 gene is linked to the fungus's ability to maintain its cell wall integrity.
💡 Why It Matters
📚 Background
Candida auris is a fungus that has emerged as a significant global health threat due to its resistance to multiple antifungal drugs. Understanding its mechanisms of resistance is crucial for developing effective treatments.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%